Desvenlafaxine
- Product NDC
- 70771-1311
- 11-digit product format
- 707711311
- Labeler code
- 70771
- Product ID
- 70771-1311_64a7578c-3dfc-44ab-ab44-62a8256d8d3b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Desvenlafaxine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA204020
- Marketing category
- ANDA
- Marketing start
- 2018-05-08
- Marketing end
- 0000-00-00
- Substance
- DESVENLAFAXINE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70771-1311-0 | 70771131100 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1311-0) | | 2018-05-08 | 0000-00-00 | No | No | Current |
| 70771-1311-1 | 70771131101 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1311-1) | | 2018-05-08 | 0000-00-00 | No | No | Current |
| 70771-1311-3 | 70771131103 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1311-3) | | 2018-05-08 | 0000-00-00 | No | No | Current |
| 70771-1311-4 | 70771131104 | 10 BLISTER PACK in 1 CARTON (70771-1311-4) > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70771-1311-2) | 10 blister pack | 2018-05-08 | 0000-00-00 | No | No | Current |
| 70771-1311-5 | 70771131105 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1311-5) | | 2018-05-08 | 0000-00-00 | No | No | Current |
| 70771-1311-7 | 70771131107 | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1311-7) | | 2018-05-08 | 0000-00-00 | No | No | Current |
| 70771-1311-9 | 70771131109 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1311-9) | | 2018-05-08 | 0000-00-00 | No | No | Current |